JP2024539499A - 神経修復を促進するためのイソロイホリン及びその誘導体の用途 - Google Patents
神経修復を促進するためのイソロイホリン及びその誘導体の用途 Download PDFInfo
- Publication number
- JP2024539499A JP2024539499A JP2024547815A JP2024547815A JP2024539499A JP 2024539499 A JP2024539499 A JP 2024539499A JP 2024547815 A JP2024547815 A JP 2024547815A JP 2024547815 A JP2024547815 A JP 2024547815A JP 2024539499 A JP2024539499 A JP 2024539499A
- Authority
- JP
- Japan
- Prior art keywords
- isorhoifolin
- nerve
- derivatives
- isoleufolin
- neurons
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271411P | 2021-10-25 | 2021-10-25 | |
| US63/271,411 | 2021-10-25 | ||
| PCT/CN2022/127372 WO2023072069A1 (zh) | 2021-10-25 | 2022-10-25 | 异野漆树苷及其衍生物用于促进神经修复的用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539499A true JP2024539499A (ja) | 2024-10-28 |
| JP2024539499A5 JP2024539499A5 (cg-RX-API-DMAC7.html) | 2025-10-28 |
Family
ID=86159046
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547815A Pending JP2024539499A (ja) | 2021-10-25 | 2022-10-25 | 神経修復を促進するためのイソロイホリン及びその誘導体の用途 |
| JP2024547816A Pending JP2024541121A (ja) | 2021-10-25 | 2022-10-25 | イソプロピル-d-グルコピラノシド誘導体、製造方法及びその用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547816A Pending JP2024541121A (ja) | 2021-10-25 | 2022-10-25 | イソプロピル-d-グルコピラノシド誘導体、製造方法及びその用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20240415859A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4424695A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024539499A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20240090982A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118215669A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI898161B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023072085A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045072A (zh) * | 2007-05-08 | 2007-10-03 | 胡军 | 山香圆叶提取物及其医药用途 |
| CN102617659A (zh) * | 2012-03-09 | 2012-08-01 | 中国烟草总公司郑州烟草研究院 | α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用 |
| CN102617658B (zh) * | 2012-03-09 | 2014-08-20 | 中国烟草总公司郑州烟草研究院 | β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用 |
| CN106167508A (zh) * | 2016-07-13 | 2016-11-30 | 上海应用技术学院 | 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法 |
-
2022
- 2022-10-25 JP JP2024547815A patent/JP2024539499A/ja active Pending
- 2022-10-25 CN CN202280071472.9A patent/CN118215669A/zh active Pending
- 2022-10-25 EP EP22885946.8A patent/EP4424695A4/en active Pending
- 2022-10-25 WO PCT/CN2022/127414 patent/WO2023072085A1/zh not_active Ceased
- 2022-10-25 KR KR1020247017445A patent/KR20240090982A/ko active Pending
- 2022-10-25 WO PCT/CN2022/127372 patent/WO2023072069A1/zh not_active Ceased
- 2022-10-25 US US18/704,869 patent/US20240415859A1/en active Pending
- 2022-10-25 CN CN202280071353.3A patent/CN118139869A/zh active Pending
- 2022-10-25 EP EP22885962.5A patent/EP4424694A4/en active Pending
- 2022-10-25 US US18/704,860 patent/US20250255893A1/en active Pending
- 2022-10-25 TW TW111140498A patent/TWI898161B/zh active
- 2022-10-25 JP JP2024547816A patent/JP2024541121A/ja active Pending
- 2022-10-25 KR KR1020247017446A patent/KR20240090983A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024541121A (ja) | 2024-11-06 |
| US20240415859A1 (en) | 2024-12-19 |
| TW202320806A (zh) | 2023-06-01 |
| CN118215669A (zh) | 2024-06-18 |
| KR20240090983A (ko) | 2024-06-21 |
| KR20240090982A (ko) | 2024-06-21 |
| EP4424694A1 (en) | 2024-09-04 |
| TWI898161B (zh) | 2025-09-21 |
| WO2023072069A1 (zh) | 2023-05-04 |
| US20250255893A1 (en) | 2025-08-14 |
| CN118139869A (zh) | 2024-06-04 |
| TW202317142A (zh) | 2023-05-01 |
| EP4424695A4 (en) | 2025-10-22 |
| EP4424695A1 (en) | 2024-09-04 |
| WO2023072085A1 (zh) | 2023-05-04 |
| EP4424694A4 (en) | 2026-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112646774B (zh) | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 | |
| TR201816335T4 (tr) | Alzheimer hastalığının tespitine yönelik optik yöntem. | |
| Tao et al. | Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye | |
| Liu et al. | A novel rat model of ocular hypertension by a single intracameral injection of cross‐linked hyaluronic acid hydrogel (Healaflow®) | |
| TWI898161B (zh) | 異野漆樹苷及其衍生物用於促進神經修復的用途 | |
| Yoo et al. | Corneal neuro-regenerative effect of transcutaneous electrical stimulation in rabbit lamellar keratectomy model | |
| CN116008558B (zh) | 细胞外基质弹性蛋白降解物在制备诊断或延缓神经退行性疾病的产品中的应用 | |
| JP2024539499A5 (cg-RX-API-DMAC7.html) | ||
| Wang et al. | Olfactory mucosa mesenchymal stem cell‐derived exosomes protect against neuroinflammation after subarachnoid hemorrhage by activating mitophagy | |
| Du et al. | Visual recovery following optic nerve crush in male and female wild-type and TRIF-deficient mice | |
| Tanriverdi et al. | Understanding of dry eye in subarachnoid hemorrhage: an experimental study on the role of facial nerve ischemia | |
| KR20140125659A (ko) | 좌뇌 내측 전전두엽의 광유전적 자극을 통한 우울증 치료방법 | |
| Shoae-Hassani et al. | Encapsulated mesenchymal stem cell-derived exosomes promote optic nerve regeneration and functional recovery in a mouse model of optic nerve crush injury | |
| RU2279886C2 (ru) | Способ улучшения функциональной активности сетчатки при ее патологии различного генеза | |
| Cai et al. | Pathologic changes in chronic intraorbital optic nerve damage in rabbits | |
| TWI823110B (zh) | 天南星科萃取物用於促進神經修復的用途 | |
| JP2024541121A5 (cg-RX-API-DMAC7.html) | ||
| CN110279685A (zh) | L-丝氨酸在预防或治疗高原颅脑损伤中的应用 | |
| CN111617234B (zh) | 外源性重组蛋白Reelin在制备治疗脑出血药物中的应用 | |
| Hwang et al. | Stem cells ameliorate neurotrauma-induced visual disturbances and retinopathy via broad normalization of the β-catenin-related signaling pathway | |
| KR102477030B1 (ko) | 인간 전분화능 줄기세포 유래 신경전구세포를 유효성분으로 포함하는 혈관성 치매 예방 또는 치료용 약학 조성물 | |
| Heng | Vision Restoration in a Newly Characterized Porcine Model of Traumatic Optic Neuropathy | |
| Fan et al. | Maternal Exposure to Sevoflurane Disrupts Oligodendrocyte Myelination of the Postnatal Hippocampus and Induces Cognitive and Motor Impairments in Offspring | |
| Luzadre | Neurogenesis and Functional Recovery of Murine Retinal Ganglion Cells After Glaucoma Induction Following Treatment With PNU-282987 | |
| Hesse | 11 Surgical Treatments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20250825 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20250825 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251003 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251020 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251017 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251118 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20260422 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20260422 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260807 |